HeartSciences Inc. (HSCS)
NASDAQ: HSCS · Real-Time Price · USD
2.670
+0.030 (1.14%)
Nov 21, 2024, 12:15 PM EST - Market open
HeartSciences Stock Forecast
HSCS's stock price has decreased by -86.27% in the past year and price targets may not have had time to catch up.
Stock Price Forecast
The 1 analyst with a 12-month price forecast for HeartSciences stock has a target of 15, which predicts an increase of 461.80% from the current stock price of 2.67.
Analyst Consensus: Strong Buy
* Price targets were last updated on Sep 23, 2024.
Analyst Ratings
According to 1 stock analyst, the rating for HeartSciences is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jun '24 | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 1 | 1 | 1 |
| Buy | 1 | 1 | 1 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 1 | 1 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Ascendiant Capital | Ascendiant Capital | Strong Buy Reiterates $15 | Strong Buy | Reiterates | $15 | +461.80% | Sep 23, 2024 |
| Ascendiant Capital | Ascendiant Capital | Strong Buy Initiates $330 | Strong Buy | Initiates | $330 | +12,259.55% | Jan 30, 2023 |
| Maxim Group | Maxim Group | Strong Buy Maintains $800 → $300 | Strong Buy | Maintains | $800 → $300 | +11,135.96% | Dec 19, 2022 |
| Maxim Group | Maxim Group | Strong Buy Initiates $800 | Strong Buy | Initiates | $800 | +29,862.55% | Nov 9, 2022 |
| Benchmark | Benchmark | Buy Initiates $800 | Buy | Initiates | $800 | +29,862.55% | Aug 8, 2022 |
Financial Forecast
Revenue This Year
1.68M
from 18.60K
Increased by 8,948.39%
Revenue Next Year
2.14M
from 1.68M
Increased by 27.27%
EPS This Year
-9.02
from -18.74
EPS Next Year
-6.20
from -9.02
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 3.4M | 3.8M | 42.0M |
| Avg | 1.7M | 2.1M | 40.8M |
| Low | 98,000 | 588,000 | 39.2M |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | 17,964.5% | 124.6% | 1,860.8% |
| Avg | 8,948.4% | 27.3% | 1,804.8% |
| Low | 426.9% | -65.1% | 1,730.1% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -8.25 | -4.00 | 10.50 |
| Avg | -9.02 | -6.20 | 10.20 |
| Low | -9.62 | -8.18 | 9.80 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.